DUBLIN, June 6, 2018 /PRNewswire/ -- Alkermes plc
(Nasdaq: ALKS) announced today that its Chief Executive Officer,
Richard Pops, will participate in a
fireside chat at the Goldman Sachs 39th Annual Global
Healthcare Conference on Wednesday, June 13,
2018 at 3:20 p.m. PT
(6:20 p.m. ET/11:20 p.m. BST) from Rancho Palos Verdes, Calif. The audio portion
of the fireside chat may be accessed under the Investors tab on
www.alkermes.com and will be archived for 14 days.
Alkermes plc is a fully integrated, global
biopharmaceutical company developing innovative medicines for the
treatment of central nervous system (CNS) diseases. The company has
a diversified commercial product portfolio and a substantial
clinical pipeline of product candidates for chronic diseases that
include schizophrenia, depression, addiction and multiple
sclerosis. Headquartered in Dublin,
Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more
information, please visit Alkermes' website
at www.alkermes.com.
Contact:
Jennifer Zibuda
Investor Relations
+1 781 609 6129
View original content with
multimedia:http://www.prnewswire.com/news-releases/alkermes-to-present-at-goldman-sachs-39th-annual-global-healthcare-conference-300661094.html
SOURCE Alkermes plc